Proteostasis Therapeutics logo
Healthcare & Life Sciences

Proteostasis Therapeutics

Proteostasis Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.

series-c-plus
series-c-plus
Stage
1
Investors

About Proteostasis Therapeutics

Proteostasis Therapeutics is a startup based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Proteostasis Therapeutics develops small-molecule therapies that modulate the cellular proteostasis network to restore function of misfolded proteins, focusing on diseases such as cystic fibrosis and other protein misfolding disorders.

Explore Proteostasis Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States